20 hospitals get failing safety grade from Leapfrog

New measures did little to change the grade distribution in the Leapfrog Group’s fall 2016 Hospital Safety Scores report.

Out of the 2,633 hospitals included in the report, “C” was the most common grade, given to 954 hospitals. An "A" was awarded to 844, 658 a “B,” 157 a “D,” and only 20 received failing grades.

The grades were in the same order in the fall 2015 and spring 2016 reports, despite the scoring methodology being updated in the spring to include data on two new infection measures (MRSA Bacteremia and C.difficile) and new patient experience measures like communication about medicines, communication about discharge, nurse communication, doctor communication and responsiveness of hospital staff.

There were changes, however, particularly at the state level, when judging by percentage of hospitals earning an “A.” North Carolina improved from No. 19 in the spring 2013 grades to No. 5 in this report, while Idaho has advanced to No. 2 from No. 45 in the same time frame.

“In the fast-changing healthcare landscape, patients should be aware that hospitals are not all equally competent at protecting them from injuries and infections,” said Leapfrog President and CEO Leah Binder. “We believe everyone has the right to know which hospitals are the safest and encourage community members to call on their local hospitals to change, and on their elected officials to spur them to action. States that put a priority on safety have shown remarkable improvements."

The top ranked state was Hawaii, while the bottom-ranked states, each with no "A" hospitals, were Alaska, Delaware and North Dakota, along with Washington, D.C.

Other states were able to climb up from that bottom rung, like Vermont, which was one of those no “A” hospital states in 2015, but was ranked eighth in this report.

 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.